(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CIPLA THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CIPLA THERAPEUTICS

ST13

US500000090218072

Class

5

Filing

90218072

Registration

7580098

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

11/26/2024

Trademark type

Combined

Nice classes

5

Filing date

09/28/2020

Registration date

11/26/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/26/2024

Last transaction

11/26/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/27/2022

First use in commerce

09/27/2022

Drawing code

3

Owner type

03

Owner location

Mumbai, Maharashtra, IN

Examiner

FRENCH, CURTIS

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "CIPLA" in stylized blue font positioned above the word "THERAPEUTICS" in stylized turquoise font with the image of the a semi-circle composed of three separate semi-circles, in blue and turquoise, which is positioned to the left of the wording. White is used for the background but is not claimed as a feature of the mark.

Holders and representatives

Holders

CIPLA LIMITED

Representatives

Stacey Halpern Knobbe, Martens, Olson & Bear, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of genitourinary diseases and disordersurological diseasesurological disordersurinary incontinence

Publications

History of USPTO decisions and trademark events.

52 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/26/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/01/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/01/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/28/2024

IUAF

USE AMENDMENT FILED

10/18/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/18/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/16/2024

EX5G

SOU EXTENSION 5 GRANTED

04/15/2024

EXT5

SOU EXTENSION 5 FILED

04/15/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/15/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/14/2023

EX4G

SOU EXTENSION 4 GRANTED

10/12/2023

EXT4

SOU EXTENSION 4 FILED

10/12/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/12/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/15/2023

EX3G

SOU EXTENSION 3 GRANTED

04/13/2023

EXT3

SOU EXTENSION 3 FILED

04/13/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/13/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/21/2022

EX2G

SOU EXTENSION 2 GRANTED

10/18/2022

EXT2

SOU EXTENSION 2 FILED

10/18/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/18/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/14/2022

EX1G

SOU EXTENSION 1 GRANTED

07/13/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/11/2022

NREV

NOTICE OF REVIVAL - E-MAILED

06/01/2022

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

05/31/2022

PETG

PETITION TO REVIVE-GRANTED

05/31/2022

PROA

TEAS PETITION TO REVIVE RECEIVED

05/31/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/31/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/31/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/31/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/31/2022

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

05/23/2022

ABN6

ABANDONMENT - NO USE STATEMENT FILED

05/23/2022

EXT1

SOU EXTENSION 1 FILED

04/19/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/24/2021

PUBO

PUBLISHED FOR OPPOSITION

08/24/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/04/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/16/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/09/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/09/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/22/2021

GNRT

NON-FINAL ACTION E-MAILED

02/22/2021

CNRT

NON-FINAL ACTION WRITTEN

02/22/2021

DOCK

ASSIGNED TO EXAMINER

02/18/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/10/2020

NWAP

NEW APPLICATION ENTERED

10/01/2020

Continuous trademark protection

Get notified about every new filing that threatens CIPLA THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.